{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:10:06Z","timestamp":1792635006065,"version":"4.5.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101333","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T11:35:32Z","timestamp":1725622532000},"page":"101333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gene therapy and kidney diseases"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-1906","authenticated-orcid":false,"given":"Nadia","family":"Tavakolidakhrabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Y.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin A.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin I.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101333_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl. (2011)"},{"key":"10.1016\/j.omtm.2024.101333_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.kint.2023.02.031","article-title":"Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events","volume":"104","author":"May","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000522226","article-title":"Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel","volume":"53","author":"Bleyer","year":"2022","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib4","series-title":"Kidney disease: A UK public health emergency","author":"Powis","year":"2023"},{"key":"10.1016\/j.omtm.2024.101333_bib5","first-page":"2002","article-title":"End stage renal disease","volume":"2007","author":"Hall","year":"2007","journal-title":"BMJ Clin. Evid."},{"key":"10.1016\/j.omtm.2024.101333_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40620-015-0219-8","article-title":"Renal cancer in kidney transplanted patients","volume":"28","author":"Frasc\u00e0","year":"2015","journal-title":"J.\u00a0Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib8","series-title":"Treating Chronic Kidney Disease","year":"2022"},{"key":"10.1016\/j.omtm.2024.101333_bib9","doi-asserted-by":"crossref","first-page":"sfae119","DOI":"10.1093\/ckj\/sfae119","article-title":"Genome editing and kidney health","volume":"17","author":"Tavakolidakhrabadi","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.omtm.2024.101333_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00041552-200307000-00013","article-title":"Applications of gene therapy to kidney disease","volume":"12","author":"Hanss","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.omtm.2024.101333_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","article-title":"Gene therapy: advances, challenges and perspectives","volume":"15","author":"Gon\u00e7alves","year":"2017","journal-title":"Einstein (Sao Paulo, Brazil)"},{"key":"10.1016\/j.omtm.2024.101333_bib12","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1681\/ASN.2008040435","article-title":"Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion","volume":"20","author":"Bastos","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2024.101333_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41581-018-0047-x","article-title":"Precision gene editing technology and applications in nephrology","volume":"14","author":"WareJoncas","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib16","doi-asserted-by":"crossref","first-page":"1035543","DOI":"10.3389\/fbioe.2022.1035543","article-title":"Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs","volume":"10","author":"Rittiner","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101333_bib17","article-title":"Four Success Stories in Gene Therapy","volume":"325","author":"Daley","year":"2021","journal-title":"Sci. Am."},{"key":"10.1016\/j.omtm.2024.101333_bib18","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s41649-018-0056-x","article-title":"Risks and benefits of human germline genome editing: An ethical analysis","volume":"10","author":"Rubeis","year":"2018","journal-title":"Asian Bioeth. Rev."},{"key":"10.1016\/j.omtm.2024.101333_bib20","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J.\u00a0Clin. Diagn. Res."},{"key":"10.1016\/j.omtm.2024.101333_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41576-021-00409-w","article-title":"A new era in functional genomics screens","volume":"23","author":"Przybyla","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2024.101333_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics Data Integration, Interpretation, and Its Application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.omtm.2024.101333_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.omtm.2024.101333_bib25","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00467-008-0840-z","article-title":"Nephronophthisis","volume":"24","author":"Salomon","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib26","series-title":"Familial Hypocalciuric Hypercalcemia","author":"Afzal","year":"2022"},{"key":"10.1016\/j.omtm.2024.101333_bib27","first-page":"33","article-title":"5. Hereditary Kidney Disorders","volume":"20","author":"Stavljeni\u0107-Rukavina","year":"2009","journal-title":"Ejifcc"},{"key":"10.1016\/j.omtm.2024.101333_bib28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(10)60236-X","article-title":"Genetic kidney diseases","volume":"375","author":"Hildebrandt","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.omtm.2024.101333_bib29","doi-asserted-by":"crossref","first-page":"eabc8226","DOI":"10.1126\/scitranslmed.abc8226","article-title":"Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome","volume":"15","author":"Ding","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41581-023-00702-3","article-title":"Cell and gene therapy for kidney disease","volume":"19","author":"Peek","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566523054065039","article-title":"Immune responses to adeno-associated virus vectors","volume":"5","author":"Zaiss","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00109-020-02034-2","article-title":"Evolving AAV-delivered therapeutics towards ultimate cures","volume":"99","author":"He","year":"2021","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib33","doi-asserted-by":"crossref","first-page":"975803","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101333_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2024.101333_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40291-020-00467-6","article-title":"Improving Molecular Therapy in the Kidney","volume":"24","author":"Rubin","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How Many Cell Types Are in the Kidney and What Do They Do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.omtm.2024.101333_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1566523044578013","article-title":"Gene therapy: how to target the kidney. Promises and pitfalls","volume":"4","author":"Tomasoni","year":"2004","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/0022034509337480","article-title":"Gene therapy: design and prospects for craniofacial regeneration","volume":"88","author":"Scheller","year":"2009","journal-title":"J.\u00a0Dent. Res."},{"key":"10.1016\/j.omtm.2024.101333_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtm.2024.101333_bib41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.abg6155","article-title":"Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery","volume":"373","author":"Segel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101333_bib42","doi-asserted-by":"crossref","first-page":"44904","DOI":"10.1038\/srep44904","article-title":"Kidney-specific transposon-mediated gene transfer in\u00a0vivo","volume":"7","author":"Woodard","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101333_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/10430340252792530","article-title":"Lentiviral gene transduction of kidney","volume":"13","author":"Gusella","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"10.1016\/j.omtm.2024.101333_bib141","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2020.09.001","article-title":"AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm","volume":"58","author":"Gangemi","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.omtm.2024.101333_bib142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lfs.2014.03.010","article-title":"MiR-204\/miR-211 downregulation contributes to candidemia-induced kidney injuries via derepression of Hmx1 expression","volume":"102","author":"Li","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.omtm.2024.101333_bib143","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajpath.2016.09.011","article-title":"miR-182-5p Inhibition Ameliorates Ischemic Acute Kidney Injury","volume":"187","author":"Wilflingseder","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2024.101333_bib144","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1681\/ASN.2015080870","article-title":"MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects against Ischemic Kidney Injury","volume":"27","author":"Wei","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.omtn.2020.10.008","article-title":"miR-150-Based RNA Interference Attenuates Tubulointerstitial Fibrosis through the SOCS1\/JAK\/STAT Pathway In\u00a0Vivo and In\u00a0Vitro","volume":"22","author":"Luan","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2024.101333_bib146","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI75852","article-title":"Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways","volume":"125","author":"Gomez","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101333_bib147","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib148","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy","volume":"23","author":"Putta","year":"2012","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib149","doi-asserted-by":"crossref","first-page":"F349","DOI":"10.1152\/ajprenal.00478.2014","article-title":"Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"308","author":"Ravichandran","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.omtm.2024.101333_bib150","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"23","author":"Ravichandran","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101333_bib151","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2004.03.016","article-title":"Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model","volume":"46","author":"Kausch","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omtm.2024.101333_bib152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bjc.6600416","article-title":"Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor","volume":"87","author":"Shi","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omtm.2024.101333_bib153","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajpath.2011.09.036","article-title":"Antisense knockdown of Kras inhibits fibrosis in a rat model of unilateral ureteric obstruction","volume":"180","author":"Wang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2024.101333_bib154","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1096\/fj.06-6713com","article-title":"Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes","volume":"21","author":"Guha","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.omtm.2024.101333_bib155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cells10030591","article-title":"Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments","volume":"10","author":"Ghanbarian","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101333_bib156","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00240-017-1004-z","article-title":"SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion","volume":"46","author":"Zeng","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.omtm.2024.101333_bib157","doi-asserted-by":"crossref","first-page":"F1617","DOI":"10.1152\/ajprenal.00279.2013","article-title":"Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3\u03b2 expression after ischemia-reperfusion injury","volume":"305","author":"Fujino","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.omtm.2024.101333_bib158","first-page":"141","article-title":"Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown","volume":"629","author":"Moore","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2024.101333_bib159","first-page":"43","article-title":"The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders","author":"Koutsilieri","year":"2007","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.omtm.2024.101333_bib160","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib161","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/TP.0000000000000960","article-title":"Attenuating Ischemia-Reperfusion Injury in Kidney Transplantation by Perfusing Donor Organs With siRNA Cocktail Solution","volume":"100","author":"Zheng","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2024.101333_bib162","doi-asserted-by":"crossref","first-page":"e0215232","DOI":"10.1371\/journal.pone.0215232","article-title":"siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice","volume":"14","author":"Narv\u00e1ez","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101333_bib163","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-021-01443-2","article-title":"ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtm.2024.101333_bib164","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.gt.3302900","article-title":"Gene therapy progress and prospects: RNA aptamers","volume":"14","author":"Que-Gewirth","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib165","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/s120100612","article-title":"Aptamers and their biological applications","volume":"12","author":"Song","year":"2012","journal-title":"Sensors"},{"key":"10.1016\/j.omtm.2024.101333_bib166","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/db16-1281","article-title":"RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy","volume":"66","author":"Matsui","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.omtm.2024.101333_bib167","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41598-018-21176-5","article-title":"RAGE-aptamer attenuates deoxycorticosterone acetate\/salt-induced renal injury in mice","volume":"8","author":"Taguchi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101333_bib168","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1038\/s41598-017-09238-6","article-title":"Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions","volume":"7","author":"Um","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101333_bib169","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2018.07.015","article-title":"Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer","volume":"12","author":"Zhang","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2024.101333_bib170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7150\/ijms.71840","article-title":"Advances in Circular RNA and Its Applications","volume":"19","author":"Zhao","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.omtm.2024.101333_bib171","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1521-2254(199903\/04)1:2<103::AID-JGM16>3.0.CO;2-O","article-title":"Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector","volume":"1","author":"McDonald","year":"1999","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101333_bib44","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.isci.2021.103243","article-title":"Renal subcapsular delivery of PGE(2) promotes kidney repair by activating endogenous Sox9(+) stem cells","volume":"24","author":"Chen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.omtm.2024.101333_bib45","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1523-1755.2002.0610s1016.x","article-title":"Adenovirus-mediated gene transfer to renal glomeruli in rodents","volume":"61","author":"Ye","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib46","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ki.1994.162","article-title":"Adenoviral-mediated gene transfer to renal tubular cells in\u00a0vivo","volume":"45","author":"Moullier","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib47","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1038\/s41598-019-50422-7","article-title":"Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy","volume":"9","author":"Newbury","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101333_bib48","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1073\/pnas.1809432115","article-title":"Targeted exon skipping of a CEP290 mutation rescues Joubert syndrome phenotypes in\u00a0vitro and in a murine model","volume":"115","author":"Ramsbottom","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101333_bib49","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3390\/pharmaceutics13122053","article-title":"New Applications of\u00a0Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery","volume":"13","author":"Niculescu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2024.101333_bib50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jconrel.2022.03.045","article-title":"Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy","volume":"345","author":"Meng","year":"2022","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101333_bib51","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","article-title":"Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells","volume":"27","author":"Wischnjow","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtm.2024.101333_bib52","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.omtm.2024.101333_bib54","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1523-1755.2000.00312.x","article-title":"Microsphere-adenoviral complexes target and transduce the glomerulus in\u00a0vivo","volume":"58","author":"Nahman","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib55","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1046\/j.1523-1755.2002.0610s1068.x","article-title":"Glomerular \u03b2-galactosidase expression following transduction with microsphere-adenoviral complexes","volume":"61","author":"Bhatt","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib56","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1523-1755.2002.0610s1016.x","article-title":"Adenovirus-mediated gene transfer to renal glomeruli in rodents","volume":"61","author":"Ye","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib57","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1046\/j.1523-1755.2002.0610s1120.x","article-title":"Aquaporin gene delivery to kidney","volume":"61","author":"Verkman","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib58","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.2002.0610s1042.x","article-title":"Targeted adenoviral gene transfer to the kidney","volume":"61","author":"McDonald","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1535676019899502","article-title":"Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges","volume":"25","author":"Ghosh","year":"2020","journal-title":"Appl. Biosaf."},{"key":"10.1016\/j.omtm.2024.101333_bib60","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.gt.3302177","article-title":"Transient foamy virus vector production by adenovirus vectors","volume":"11","author":"Russell","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/0886022X.2011.559679","article-title":"Biological effects of lentivirus-mediated shRNA targeting collagen type I on the mesangial cells of rats","volume":"33","author":"Zhou","year":"2011","journal-title":"Ren. Fail."},{"key":"10.1016\/j.omtm.2024.101333_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbiotec.2016.10.016","article-title":"Challenges of up-scaling lentivirus production and processing","volume":"240","author":"McCarron","year":"2016","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.omtm.2024.101333_bib63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/pharmaceutics12111051","article-title":"Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges","volume":"12","author":"Mart\u00ednez-Molina","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2024.101333_bib64","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101333_bib65","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks Associated With Lentiviral Vector Exposures and Prevention Strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J.\u00a0Occup. Environ. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib66","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.ymthe.2020.05.019","article-title":"Efficient Nuclease-Directed Integration of Lentivirus Vectors into the Human Ribosomal DNA Locus","volume":"28","author":"Schenkwein","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtm.2019.12.008","article-title":"Immune Response Mechanisms against AAV Vectors in Animal Models","volume":"17","author":"Martino","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101333_bib68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101333_bib69","doi-asserted-by":"crossref","first-page":"e76310","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101333_bib70","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V1091908","article-title":"Transduction of Renal Cells in\u00a0Vitro and in\u00a0Vivo by Adeno-Associated Virus Gene Therapy Vectors","volume":"10","author":"Lipkowitz","year":"1999","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib71","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.ASN.0000057858.45649.F7","article-title":"Gene Delivery in Renal Tubular Epithelial Cells Using Recombinant Adeno-Associated Viral Vectors","volume":"14","author":"Chen","year":"2003","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib72","article-title":"Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids","author":"Furusho","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2024.101333_bib73","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1681\/ASN.2018040426","article-title":"Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector","volume":"29","author":"Ikeda","year":"2018","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.omtm.2019.09.003","article-title":"Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors","volume":"15","author":"Eichhoff","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101333_bib75","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V1091908","article-title":"Transduction of renal cells in\u00a0vitro and in\u00a0vivo by adeno-associated virus gene therapy vectors","volume":"10","author":"Lipkowitz","year":"1999","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib76","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.gt.3302768","article-title":"AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage","volume":"13","author":"Wang","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib77","series-title":"Novel Gene Therapy Approaches","article-title":"Targeted Gene Delivery: Importance of Administration Routes","author":"Shintaro","year":"2013"},{"key":"10.1016\/j.omtm.2024.101333_bib78","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/v12091016","article-title":"Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy","volume":"12","author":"Gutierrez-Guerrero","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2024.101333_bib79","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1093\/nar\/gkac587","article-title":"Highly efficient CRISPR-mediated large DNA docking and multiplexed prime editing using a single baculovirus","volume":"50","author":"Aulicino","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2024.101333_bib80","series-title":"PEI and its derivatives for gene therapy","first-page":"29","author":"Bahadur","year":"2016"},{"key":"10.1016\/j.omtm.2024.101333_bib81","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mt.2009.91","article-title":"The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice","volume":"17","author":"Gao","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib82","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1039\/b918869j","article-title":"Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in\u00a0vitro and in\u00a0vivo","volume":"6","author":"Laursen","year":"2010","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.omtm.2024.101333_bib83","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1093\/nar\/gks033","article-title":"In\u00a0vivo screening of modified siRNAs for non-specific antiviral effect in a small fish model: number and localization in the strands are important","volume":"40","author":"Schyth","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2024.101333_bib84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/thno.9717","article-title":"Chitosan\/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.omtm.2024.101333_bib85","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7150\/thno.7866","article-title":"Megalin-mediated specific uptake of chitosan\/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing","volume":"4","author":"Gao","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.omtm.2024.101333_bib86","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1172\/JCI429","article-title":"Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in\u00a0vitro and in\u00a0vivo","volume":"101","author":"Maeshima","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101333_bib87","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1006\/bbrc.1993.2356","article-title":"Efficient gene transfer with less cytotoxicity by means of cationic multilamellar liposomes","volume":"196","author":"Yagi","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib88","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1016\/S0021-9258(18)63828-1","article-title":"Introduction and expression of the human insulin gene in adult rat liver","volume":"264","author":"Kaneda","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101333_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-291X(05)80784-3","article-title":"Direct in\u00a0vivo gene introduction into rat kidney","volume":"186","author":"Tomita","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.1996.297","article-title":"Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis","volume":"50","author":"Akagi","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.06.122","article-title":"Transcription factor decoy technology: A therapeutic update","volume":"144","author":"Hecker","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtm.2024.101333_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10157-007-0459-6","article-title":"Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease","volume":"11","author":"Tomita","year":"2007","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib93","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.gt.3302696","article-title":"Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction","volume":"13","author":"Chae","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib94","doi-asserted-by":"crossref","first-page":"14640","DOI":"10.1073\/pnas.192581499","article-title":"Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells","volume":"99","author":"Thomas","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101333_bib95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-3659(03)00076-2","article-title":"Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in\u00a0vivo distribution with high-molecular-weight polyethylenimine","volume":"89","author":"Kunath","year":"2003","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101333_bib96","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1166\/jnn.2012.6372","article-title":"Kidney-specific peptide-conjugated poly(ester amine) for the treatment of kidney fibrosis","volume":"12","author":"Kim","year":"2012","journal-title":"J.\u00a0Nanosci. Nanotechnol."},{"key":"10.1016\/j.omtm.2024.101333_bib97","series-title":"Pharmaceutical Applications of Dendrimers","first-page":"211","article-title":"9 - Dendrimers in gene delivery","author":"Rai","year":"2020"},{"key":"10.1016\/j.omtm.2024.101333_bib98","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/mthe.2000.0142","article-title":"Development of Biomaterials for Gene Therapy","volume":"2","author":"Han","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib99","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jgm.419","article-title":"IONP-PLL: a novel non-viral vector for efficient gene delivery","volume":"5","author":"Xiang","year":"2003","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101333_bib100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mabi.201100277","article-title":"Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue","volume":"12","author":"Dolman","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.omtm.2024.101333_bib101","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1073\/pnas.1808168115","article-title":"l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier","volume":"115","author":"Matsuura","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101333_bib102","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/10715762.2019.1697437","article-title":"S-nitrosylated l-serine-modified dendrimer as a kidney-targeting nitric oxide donor for prevention of renal ischaemia\/reperfusion injury","volume":"54","author":"Katsumi","year":"2020","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.omtm.2024.101333_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/pharmaceutics4010130","article-title":"Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA","volume":"4","author":"Arima","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2024.101333_bib104","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/bc025557d","article-title":"Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin","volume":"13","author":"Kihara","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtm.2024.101333_bib105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/bc025613a","article-title":"In\u00a0vitro and in\u00a0vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer","volume":"14","author":"Kihara","year":"2003","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtm.2024.101333_bib106","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jconrel.2005.02.016","article-title":"Improvement of gene delivery mediated by mannosylated dendrimer\/\u03b1-cyclodextrin conjugates","volume":"104","author":"Wada","year":"2005","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101333_bib107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MNH.0000000000000768","article-title":"Gene therapy for kidney disease: targeting cystinuria","volume":"31","author":"Peek","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.omtm.2024.101333_bib108","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40097-021-00399-5","article-title":"Milk protein-based nanodelivery systems for the cancer treatment","volume":"11","author":"Tavakoli","year":"2021","journal-title":"J.\u00a0Nanostruct. Chem."},{"key":"10.1016\/j.omtm.2024.101333_bib109","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.117.09843","article-title":"Selective Nanoparticle Targeting of the Renal Tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.omtm.2024.101333_bib110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib111","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","article-title":"siRNA-based therapy ameliorates glomerulonephritis","volume":"21","author":"Shimizu","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib112","doi-asserted-by":"crossref","first-page":"e102886","DOI":"10.1371\/journal.pone.0102886","article-title":"A magnetic nanoparticle-based multiple-gene delivery system for transfection of porcine kidney cells","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101333_bib113","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.msec.2017.05.068","article-title":"Efficient megalin targeted delivery to renal proximal tubular cells mediated by modified-polymyxin B-polyethylenimine based nano-gene-carriers","volume":"79","author":"Oroojalian","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.omtm.2024.101333_bib114","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.3346\/jkms.2021.36.e333","article-title":"Vimentin Targeted Nano-gene Carrier for Treatment of Renal Diseases","volume":"36","author":"Mathew","year":"2021","journal-title":"J.\u00a0Korean Med. Sci."},{"key":"10.1016\/j.omtm.2024.101333_bib115","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.2147\/IJN.S82587","article-title":"Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in\u00a0vivo","volume":"10","author":"Morishita","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omtm.2024.101333_bib116","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2020.01.024","article-title":"Co-delivery of p38\u03b1 MAPK and p65 siRNA by novel liposomal glomerulus-targeting nano carriers for effective immunoglobulin a nephropathy treatment","volume":"320","author":"Wang","year":"2020","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtm.2024.101333_bib117","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1006\/bbrc.1996.1444","article-title":"Gene Transfer of Interleukin-1 Receptor Antagonist into the Renal Glomerulus via a Mesangial Cell Vector","volume":"226","author":"Yokoo","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib118","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI117361","article-title":"Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in\u00a0vivo","volume":"94","author":"Kitamura","year":"1994","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101333_bib119","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s100590000027","article-title":"Gene Delivery into Rat Glomerulus Using a Mesangial Cell Vector","volume":"10","author":"Kim","year":"2000","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omtm.2024.101333_bib120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yexmp.2004.07.006","article-title":"Ex\u00a0vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis","volume":"78","author":"Huijun","year":"2005","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.omtm.2024.101333_bib121","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1556-276X-7-451","article-title":"Transgene therapy for rat anti-Thy1.1 glomerulonephritis via mesangial cell vector with a polyethylenimine\/decorin nanocomplex","volume":"7","author":"Sun","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.omtm.2024.101333_bib122","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1006\/bbrc.1996.1444","article-title":"Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector","volume":"226","author":"Yokoo","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2024.101333_bib123","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1089\/hum.1998.9.12-1731","article-title":"Inflamed site-specific gene delivery using bone marrow-derived CD11b+CD18+ vehicle cells in mice","volume":"9","author":"Yokoo","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib124","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1159\/000072494","article-title":"Targeting genetically modified macrophages to the glomerulus","volume":"94","author":"Wilson","year":"2003","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.omtm.2024.101333_bib125","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1089\/10430349950016717","article-title":"Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells","volume":"10","author":"Yokoo","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib126","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.166.1.609","article-title":"Genetically Modified Bone Marrow-Derived Vehicle Cells Site Specifically Deliver an Anti-Inflammatory Cytokine to Inflamed Interstitium of Obstructive Nephropathy1","volume":"166","author":"Yamagishi","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2024.101333_bib127","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.4049\/jimmunol.166.7.4728","article-title":"Macrophages Transfected with Adenovirus to Express IL-4 Reduce Inflammation in Experimental Glomerulonephritis1","volume":"166","author":"Kluth","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2024.101333_bib128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/mthe.2002.0802","article-title":"Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis","volume":"6","author":"Wilson","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101333_bib129","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.2002.0610s1125.x","article-title":"c-myc antisense oligonucleotide treatment ameliorates murine ARPKD","volume":"61","author":"Ricker","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib130","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI116874","article-title":"Glomerulosclerosis induced by in\u00a0vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney","volume":"92","author":"Isaka","year":"1993","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101333_bib131","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41401-020-0463-x","article-title":"KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury","volume":"42","author":"Xu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omtm.2024.101333_bib132","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1046\/j.1523-1755.2002.0610s1056.x","article-title":"Gene therapy and solid-organ transplantation","volume":"61","author":"Akalin","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2024.101333_bib133","first-page":"766","article-title":"SHARP-2 gene silencing by lentiviral-based short hairpin RNA interference prolonged rat kidney transplant recipients' survival time","volume":"37","author":"Shou","year":"2009","journal-title":"J.\u00a0Int. Med. Res."},{"key":"10.1016\/j.omtm.2024.101333_bib134","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2020.00265","article-title":"Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex\u00a0vivo Organ Perfusion","volume":"11","author":"Yuzefovych","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2024.101333_bib135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/00007890-199603150-00023","article-title":"Molecular conjugate-mediated gene transfer into isolated human kidneys1","volume":"61","author":"Zeigler","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2024.101333_bib136","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1038\/srep11061","article-title":"A minimally invasive, lentiviral based method for the rapid and sustained genetic manipulation of renal tubules","volume":"5","author":"Espana-Agusti","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101333_bib137","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF03401628","article-title":"Macrophage growth factors introduced into the kidney initiate renal injury","volume":"2","author":"Naito","year":"1996","journal-title":"Mol. Med."},{"key":"10.1016\/j.omtm.2024.101333_bib138","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.ejhg.5201535","article-title":"Large animal models and gene therapy","volume":"14","author":"Casal","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2024.101333_bib139","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3343\/alm.2023.0382","article-title":"Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation","volume":"44","author":"Lee","year":"2024","journal-title":"Ann. Lab. Med."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:05:55Z","timestamp":1737648355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":171,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2329050124001499"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101333","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy and kidney diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101333"}}